Cargando…

A Selective Histone Deacetylase Inhibitor Induces Autophagy and Cell Death via SCNN1A Downregulation in Glioblastoma Cells

SIMPLE SUMMARY: Glioblastoma multiforme (GBM) patients have a poor prognosis. Recent literature has shown that GBM treatment is challenging, mainly due to the heterogeneity of GBM. Epigenetic deregulation by histone modifications is found in GBM. In this study, several pan- and specific histone deac...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chang, Hui Hua, Chang, Yao-Yuan, Tsai, Bing-Chen, Chen, Li-Jyun, Chang, An-Chi, Chuang, Jian-Ying, Gean, Po-Wu, Hsueh, Yuan-Shuo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9496778/ https://www.ncbi.nlm.nih.gov/pubmed/36139696 http://dx.doi.org/10.3390/cancers14184537

Ejemplares similares

Histone deacetylase 6 acts upstream of DNA damage response activation to support the survival of glioblastoma cells
por: Yang, Wen-Bin, et al.
Publicado: (2021)

The application of histone deacetylases inhibitors in glioblastoma
por: Chen, Rui, et al.
Publicado: (2020)

Histone Deacetylase Inhibitors Impair Glioblastoma Cell Motility and Proliferation
por: Rampazzo, Elena, et al.
Publicado: (2022)

Histone Deacetylase Inhibitors Downregulate Calcium Pyrophosphate Crystal Formation in Human Articular Chondrocytes
por: Chang, Chi-Ching, et al.
Publicado: (2022)

Histone deacetylase 3 binds to and regulates the GCMa transcription factor
por: Chuang, Hsiao-Ching, et al.
Publicado: (2006)

DNA Methylation Patterns Correlate with the Expression of SCNN1A, SCNN1B, and SCNN1G (Epithelial Sodium Channel, ENaC) Genes
por: Pierandrei, Silvia, et al.
Publicado: (2021)

Histone Deacetylase Inhibitors Impair Vasculogenic Mimicry from Glioblastoma Cells
por: Pastorino, Olga, et al.
Publicado: (2019)

Histone deacetylase enzymes and selective histone deacetylase inhibitors for antitumor effects and enhancement of antitumor immunity in glioblastoma
por: Yelton, Caleb J., et al.
Publicado: (2018)

Synergistic inhibition of tumor growth by combination treatment with drugs against different subpopulations of glioblastoma cells
por: Chang, Chia-Hsin, et al.
Publicado: (2017)

Histone deacetylase inhibitor MGCD0103 causes cell cycle arrest, apoptosis, and autophagy in liver cancer cells
por: Liao, Bo, et al.
Publicado: (2020)

Proliferative regulation of alveolar epithelial type 2 progenitor cells by human Scnn1d gene
por: Zhao, Runzhen, et al.
Publicado: (2019)

Autophagy-related cell death by pan-histone deacetylase inhibition in liver cancer
por: Di Fazio, Pietro, et al.
Publicado: (2016)

Histone Deacetylase Inhibitor-Induced Autophagy in Tumor Cells: Implications for p53
por: Mrakovcic, Maria, et al.
Publicado: (2017)

A novel histone deacetylase inhibitor, CKD5, has potent anti-cancer effects in glioblastoma
por: Choi, Seung Ah, et al.
Publicado: (2016)

Histone Deacetylases and Histone Deacetylase Inhibitors in Neuroblastoma
por: Phimmachanh, Monica, et al.
Publicado: (2020)

Impact of PKCε downregulation on autophagy in glioblastoma cells
por: Toton, Ewa, et al.
Publicado: (2018)

Therapeutic Opportunities of Targeting Histone Deacetylase Isoforms to Eradicate Cancer Stem Cells
por: Lin, Peng-Chan, et al.
Publicado: (2018)

Association of SCNN1A Single Nucleotide Polymorphisms with neonatal respiratory distress syndrome
por: Li, Wang, et al.
Publicado: (2015)

Snail regulation in fibroblast-like synoviocytes by a histone deacetylase or glycogen synthase kinase inhibitor affects cell proliferation and gene expression
por: Shen, Po-Chuan, et al.
Publicado: (2021)

The histone deacetylase inhibitor PCI-24781 as a putative radiosensitizer in pediatric glioblastoma cell lines
por: de Andrade, Pamela Viani, et al.
Publicado: (2016)

Enhanced efficacy of histone deacetylase inhibitor combined with bromodomain inhibitor in glioblastoma
por: Meng, Wei, et al.
Publicado: (2018)

Histone deacetylase 9 regulates breast cancer cell proliferation and the response to histone deacetylase inhibitors
por: Lapierre, Marion, et al.
Publicado: (2016)

Simvastatin reduces the carcinogenic effect of 3-methylcholanthrene in renal epithelial cells through histone deacetylase 1 inhibition and RhoA reactivation
por: Chang, Chih-Cheng, et al.
Publicado: (2019)

Different Modes of Action of Genetic and Chemical Downregulation of Histone Deacetylases with Respect to Plant Development and Histone Modifications
por: Lochmanová, Gabriela, et al.
Publicado: (2019)

Novel histone deacetylase inhibitor N25 exerts anti-tumor effects and induces autophagy in human glioma cells by inhibiting HDAC3
por: Sun, Xin-Yuan, et al.
Publicado: (2017)

Histone deacetylase inhibitors induce apoptosis in myeloid leukemia by suppressing autophagy
por: Stankov, Metodi V., et al.
Publicado: (2013)

Possible Role of Autophagy in the Treatment of Pancreatic Cancer with Histone Deacetylase Inhibitors
por: Rikiishi, Hidemi
Publicado: (2010)

Effects of caffeine on cell viability and activity of histone deacetylase 1 and histone acetyltransferase in glioma cells
por: Chen, Jin-Cherng, et al.
Publicado: (2016)

Histone deacetylase inhibitors suppress mutant p53 transcription via histone deacetylase 8
por: Yan, Wensheng, et al.
Publicado: (2012)

Effects of valproic acid on histone deacetylase inhibition in vitro and in glioblastoma patient samples
por: Berendsen, Sharon, et al.
Publicado: (2019)

Remarkable response of a patient with secondary glioblastoma to a histone deacetylase inhibitor
por: Gurbani, Saumya S, et al.
Publicado: (2020)

Synergistic Anticancer Effect of Glycolysis and Histone Deacetylases Inhibitors in a Glioblastoma Model
por: Pająk, Beata, et al.
Publicado: (2021)

Beyond Histone and Deacetylase: An Overview of Cytoplasmic Histone Deacetylases and Their Nonhistone Substrates
por: Yao, Ya-Li, et al.
Publicado: (2011)

Silencing of Histone Deacetylase 6 Decreases Cellular Malignancy and Contributes to Primary Cilium Restoration, Epithelial-to-Mesenchymal Transition Reversion, and Autophagy Inhibition in Glioblastoma Cell Lines
por: Urdiciain, Alejandro, et al.
Publicado: (2021)

Author Correction: Simvastatin reduces the carcinogenic effect of 3-methylcholanthrene in renal epithelial cells through histone deacetylase 1 inhibition and RhoA reactivation
por: Chang, Chih-Cheng, et al.
Publicado: (2020)

Histone Deacetylase Inhibition and Autophagy Modulation Induces a Synergistic Antiproliferative Effect and Cell Death in Cholangiocarcinoma Cells
por: Yenigül, Münevver, et al.
Publicado: (2023)

Role of Histone Deacetylases in T-Cell Development and Function
por: Pieniawska, Monika, et al.
Publicado: (2022)

The Roles of Histone Deacetylases and Their Inhibitors in Cancer Therapy
por: Li, Guo, et al.
Publicado: (2020)

Histone deacetylase 6 in cancer
por: Li, Ting, et al.
Publicado: (2018)

Statins and Histone Deacetylase Inhibitors Affect Lamin A/C – Histone Deacetylase 2 Interaction in Human Cells
por: Mattioli, Elisabetta, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_q1j68bm9vtoe7b4na3j5it3cor